tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market
NRIX
Nurix Therapeutics
Stock Analysis
Analyst Forecasts
News & Insights
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding NRIX?
Track your performance easily
Link Broker

Nurix Therapeutics (NRIX) Stock News & Sentiment

407 Followers
Nurix Therapeutics Reports Promising Trial Results for NX-5948
Premium
Company Announcements
Nurix Therapeutics Reports Promising Trial Results for NX-5948
12d ago
8K
NRIX
Nurix Therapeutics Appoints Anil Kapur to Board
Premium
Company Announcements
Nurix Therapeutics Appoints Anil Kapur to Board
2M ago
8K
NRIX
Nurix Therapeutics Braces for Stricter Disclosure Rules as Market Value Grows
Premium
Company Announcements
Nurix Therapeutics Braces for Stricter Disclosure Rules as Market Value Grows
2M ago
NRIX
Nurix Therapeutics, Inc. (NRIX) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Nurix Therapeutics, Inc. (NRIX) Q3 Earnings Cheat Sheet
2M ago
NRIX
Nurix Therapeutics Showcases Breakthrough BTK Degraders
Premium
Company Announcements
Nurix Therapeutics Showcases Breakthrough BTK Degraders
4M ago
8K
NRIX
Is NRIX a Buy, Before Earnings?
Premium
Pre-Earnings
Is NRIX a Buy, Before Earnings?
6M ago
NRIX
Nurix Therapeutics Reports Promising NX-5948 Trial Results
Premium
Company Announcements
Nurix Therapeutics Reports Promising NX-5948 Trial Results
6M ago
8K
NRIX
More NRIX News >

NRIX News on the Web

Nurix Therapeutics (NRIX) Receives a Buy from Stifel Nicolaus
TipRanks News
Bullish
Morgan Stanley's Strategic Reduction in Nurix Therapeutics Holdings
GuruFocus News
Neutral
Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit
Yahoo Finance
Neutral
Promising Data on Nurix Therapeutics’ NX-5948 Supports Buy Rating for Waldenstrom’s Macroglobulinemia Treatment
TipRanks News
Bullish
Nurix Therapeutics’ NX-5948 shows promise in Waldenstrom’s macroglobulinaemia trial
Clinical Trials Arena
Neutral
Nurix Reports Positive Results For BTK Degrader NX-5948 In Waldenstrom's Macroglobulinemia
rttnews
Neutral
Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia
Yahoo Finance
Neutral
Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
NRIX
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NRIX’s Media Buzz Sentiment?
1 articles about NRIX were published this week. In an average week, 1 articles are published.
    What is NRIX’s weekly average amount of articles?
    In an average week, 1 articles about NRIX are published.
      What is NRIX’s News Sentiment?
      100% of articles about NRIX were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        CADLCandel Therapeutics
        VRDNViridian Therapeutics
        RPTXRepare Therapeutics
        QUREuniQure
        VCYTVeracyte
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing